持续胰岛素输注治疗2型糖尿病的效果分析被引量：11

原文传递

导出

摘要 2型糖尿病（T2DM）的病理生理基础为胰岛素抵抗（IR）和β细胞功能减退。为保护胰岛β细胞残存功能，尽快纠正患者高血糖状态，我们采用胰岛素泵持续皮下输注胰岛素治疗86例糖尿病高血糖患者，现报告如下。

作者秦清泉李忆琴梅俪凡方思伟邱鸿凯

机构地区南方医科大学附属中山博爱医院内分泌科

出处《中国基层医药》 CAS 2009年第4期706-707,共2页 Chinese Journal of Primary Medicine and Pharmacy

关键词 2型糖尿病胰岛素抵抗输注治疗 Β细胞功能减退高血糖状态病理生理基础持续皮下输注胰岛β细胞

分类号 R587 [医药卫生—内分泌]

引文网络
相关文献

参考文献5

1Iikova H, Giaser B,Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,21 ( 20 ) : 1353- 1356.
2祝方,纪立农,韩学尧,朱宇,张红杰,周翔海,陈静,蔡晓陵,张明霞.短期胰岛素强化治疗诱导初诊2型糖尿病患者血糖长期良好控制的临床试验[J].中国糖尿病杂志,2003,11(1):5-9. 被引量：854
3Philip R,Bruce W,Jenifer B,et al. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes. Diabetes Care,2003,25(26) :2598-2603.
4陈永松,林建才,许文灿,林少达,林丹,詹勇平.胰岛素泵短期治疗2型糖尿病的临床观察[J].河北医学,2003,9(5):389-392. 被引量：7
5翁建平,李延兵,许雯,陈小华,廖志红,姚斌,邓婉萍,欧香忠,胡国亮.短期持续胰岛素输注治疗对初诊2型糖尿病患者胰岛β细胞功能的影响[J].中国糖尿病杂志,2003,11(1):10-15. 被引量：780

二级参考文献22

1Weyer. Dificiency in AIR predict IGT and Type 2 diabetes. Diabetes Care, 2001,24 : 89-94.
2Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes, 1995,44: 1386-1391.
3Bruce DG, Chisholm DJ, Leonare H, et al. Physiological importance of deficiency in early prandial insulin secretion in non-in-sulin-dependent diabetes. Diabetes, 1988,37: 736-743.
4Bruttomesso D, Pianta A, Mari A, et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes, 1999,48: 99-105.
5Ilkova H, glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20:1353-1356.
6Walton C, Godsland IF, Proudler AJ, et al. Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men. J Clin Endocrinol Metab,1992,75: 170-175.
7Purrello F, Rabuazza AM. Metabolic factors that affect betacell function and survival. Diabet Nutr Metab, 2000, 13: 84-91.
8Sivitz WI. Lipotoxieity and glueotoxieity in type 2 diabetes. Effects on development and progression. Postgrad Med, 2001,109: 55-59,63-64.
9Lenhard M J, Reeves GD. Continous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med,2001,161: 2293-2300.
10Dupuy O, Mayaudon H, Palou M, et al. Optimized transient insulin infusion in uneontrolled type 2 Diabetes : Evaluation of a pragmatie attitude. Diabet Med, 2000,26 : 371-375.